Request Deal Involvement
MoonLake Immunotherapeutics went public via a SPAC merger with Cormorant-backed Helix Acquisition in a $230m deal.
Identify your role
Select the side you represented in this transaction, and provide your current job title.
Service Providers
pr advisors
Consilium Strategic Communications
legal advisors
Walkers
pr advisors
MacDougall
legal advisors
Kellerhals Carrard
legal advisors
Kirkland & Ellis
legal advisors
Gibson Dunn & Crutcher
legal advisors
Pestalozzi Attorneys at Law
legal advisors
White & Case
financial advisors
Leerink Partners
legal advisors
Maples Group
financial advisors
Jefferies & Company
financial advisors
TD Cowen
legal advisors to financial advisors
Fried Frank Harris Shriver & Jacobson
or
Principals
bidder
BVF PARTNERS
bidder
RTW INVESTMENTS
target
MOONLAKE IMMUNOTHERAPEUTICS
bidder
MONASHEE INVESTMENT MANAGEMENT
bidder
HELIX ACQUISITION
bidder
CORMORANT ASSET MANAGEMENT
bidder
683 CAPITAL PARTNERS
bidder
ASYMMETRY CAPITAL MANAGEMENT
bidder
GHOST TREE CAPITAL
bidder
SURVEYOR CAPITAL
bidder
TCG X
bidder
TEKLA CAPITAL MANAGEMENT LLC
Principals or Service Provider not listed?Add missing Service Provider or Principal
Enter your Job Title on this deal
This title will appear on your profile next to this deal involvement.
To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:
All rights reserved. Copyright © 2025 Datasite